A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression-Reference-Cited by-同舟云学术

A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression

Published:2017-08-03 Issue:8 Volume:12 Page:e0182098
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Llano Daniel A.^ORCID,Bundela Saurabh,Mudar Raksha A.,Devanarayan Viswanath,

Funder

National Institute on Aging

U.S. Department of Defense

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference72 articles.

1. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria;B Dubois;The Lancet Neurology,2007

2. Improving CSF biomarkers’ performance for predicting progression from mild cognitive impairment to Alzheimer’s disease by considering different confounding factors: a meta-analysis;D Ferreira;Frontiers in Aging Neuroscience,2014

3. Decreased β-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease;T Sunderland;JAMA,2003

4. Relationships among cerebrospinal fluid biomarkers in dementia of the Alzheimer type;JG Csernansky;Alzheimer Disease & Associated Disorders,2002

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Neurobehavioral and Glial Responses to Explosion Gas Inhalation in Rats;Environmental Toxicology;2024-08-02

2. Plasma pTau181 enhances the prediction of future clinical decline in amyloid‐positive mild cognitive impairment;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-07

3. Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies;2024-03-28

4. Predicting 5‐year dementia conversion in veterans with mild cognitive impairment;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

5. Emerging biomarkers for early diagnosis of noncommunicable diseases;Health and Environmental Applications of Biosensing Technologies;2024